Auxin-cytokinin and auxin-gibberellin interactions during morphogenesis of the compound leaves of pea (Pisum sativum).
A number of mutations that alter the form of the compound leaf in pea (Pisum sativum) has proven useful in elucidating the role that auxin might play in pea leaf development. The goals of this study were to determine if auxin application can rescue any of the pea leaf mutants and if gibberellic acid (GA) plays a role in leaf morphogenesis in pea. A tissue culture system was used to determine the effects of various auxins, GA or a GA biosynethesis inhibitor (paclobutrazol) on leaf development. The GA mutant, nana1 (na1) was analyzed. The uni-tac mutant was rescued by auxin and GA and rescue involved both a conversion of the terminal leaflet into a tendril and an addition of a pair of lateral tendrils. This rescue required the presence of cytokinin. The auxins tested varied in their effectiveness, although methyl-IAA worked best. The terminal tendrils of wildtype plantlets grown on paclobutrazol were converted into leaflets, stubs or were aborted. The number of lateral pinna pairs produced was reduced and leaf initiation was impaired. These abnormalities resembled those caused by auxin transport inhibitors and phenocopy the uni mutants. The na1 mutant shared some morphological features with the uni mutants; including, flowering late and producing leaves with fewer lateral pinna pairs. These results show that both auxin and GA play similar and significant roles in pea leaf development. Pea leaf morphogenesis might involve auxin regulation of GA biosynthesis and GA regulation of Uni expression.
DeMason
Darleen A
DA
Department of Botany and Plant Sciences, University of California, Riverside, CA 92521, USA. demason@ucrac1.ucr.edu
D001593:Benzyl Compounds / Q000494:pharmacology; D003583:Cytokinins / Q000378:metabolism* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005838:Genotype; D005875:Gibberellins / Q000378:metabolism* / Q000494:pharmacology; D007210:Indoleacetic Acids / Q000378:metabolism* / Q000494:pharmacology; D009024:Morphogenesis / Q000187:drug effects; D009154:Mutation; D009280:Naphthaleneacetic Acids / Q000378:metabolism / Q000494:pharmacology; D018532:Pisum sativum / Q000187:drug effects / Q000235:genetics / Q000254:growth & development* / Q000648:ultrastructure; D010937:Plant Growth Regulators / Q000378:metabolism* / Q000494:pharmacology; D018515:Plant Leaves / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism* / Q000648:ultrastructure; D018520:Plant Shoots / Q000254:growth & development / Q000648:ultrastructure; D011687:Purines / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology
D001593:Benzyl Compounds; D003583:Cytokinins; D005875:Gibberellins; D007210:Indoleacetic Acids; D009280:Naphthaleneacetic Acids; D010937:Plant Growth Regulators; D011687:Purines; D014230:Triazoles; C053370:paclobutrazol; C030737:indoleacetic acid; C480551:benzylaminopurine